Rhodes JM - Search Results

1

Challenging the surgical rodent hindlimb ischemia model with the miniinterventional technique.

Zhuang ZW, Shi J, Rhodes JM, Tsapakos MJ, Simons M. Zhuang ZW, et al. Among authors: rhodes jm. J Vasc Interv Radiol. 2011 Oct;22(10):1437-46. doi: 10.1016/j.jvir.2010.12.039. Epub 2011 Apr 3. J Vasc Interv Radiol. 2011. PMID: 21459613 Free PMC article.

2

N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA₁₆₅-dependent neovascularization.

Corti F, Wang Y, Rhodes JM, Atri D, Archer-Hartmann S, Zhang J, Zhuang ZW, Chen D, Wang T, Wang Z, Azadi P, Simons M. Corti F, et al. Among authors: rhodes jm. Nat Commun. 2019 Apr 5;10(1):1562. doi: 10.1038/s41467-019-09605-z. Nat Commun. 2019. PMID: 30952866 Free PMC article.

3

Publisher Correction: N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA₁₆₅-dependent neovascularization.

Corti F, Wang Y, Rhodes JM, Atri D, Archer-Hartmann S, Zhang J, Zhuang ZW, Chen D, Wang T, Wang Z, Azadi P, Simons M. Corti F, et al. Among authors: rhodes jm. Nat Commun. 2019 May 7;10(1):2124. doi: 10.1038/s41467-019-10205-0. Nat Commun. 2019. PMID: 31064993 Free PMC article.

4

The extracellular matrix and blood vessel formation: not just a scaffold.

Rhodes JM, Simons M. Rhodes JM, et al. J Cell Mol Med. 2007 Mar-Apr;11(2):176-205. doi: 10.1111/j.1582-4934.2007.00031.x. J Cell Mol Med. 2007. PMID: 17488472 Free PMC article. Review.

5

Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling.

Baeyens N, Mulligan-Kehoe MJ, Corti F, Simon DD, Ross TD, Rhodes JM, Wang TZ, Mejean CO, Simons M, Humphrey J, Schwartz MA. Baeyens N, et al. Among authors: rhodes jm. Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17308-13. doi: 10.1073/pnas.1413725111. Epub 2014 Nov 17. Proc Natl Acad Sci U S A. 2014. PMID: 25404299 Free PMC article.

6

Syndecans: new kids on the signaling block.

Tkachenko E, Rhodes JM, Simons M. Tkachenko E, et al. Among authors: rhodes jm. Circ Res. 2005 Mar 18;96(5):488-500. doi: 10.1161/01.RES.0000159708.71142.c8. Circ Res. 2005. PMID: 15774861 Review.

7

Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway.

Elfenbein A, Rhodes JM, Meller J, Schwartz MA, Matsuda M, Simons M. Elfenbein A, et al. Among authors: rhodes jm. J Cell Biol. 2009 Jul 13;186(1):75-83. doi: 10.1083/jcb.200810179. Epub 2009 Jul 6. J Cell Biol. 2009. PMID: 19581409 Free PMC article.

8

Synectin/syndecan-4 regulate coronary arteriolar growth during development.

Dedkov EI, Thomas MT, Sonka M, Yang F, Chittenden TW, Rhodes JM, Simons M, Ritman EL, Tomanek RJ. Dedkov EI, et al. Among authors: rhodes jm. Dev Dyn. 2007 Jul;236(7):2004-10. doi: 10.1002/dvdy.21201. Dev Dyn. 2007. PMID: 17576142 Free article.

9

The CNS Relapse in T-Cell Lymphoma Index Predicts CNS Relapse in Patients with T- and NK-Cell Lymphomas.

Bhansali RS, Ellin F, Relander T, Cao M, Li W, Long Q, Ganesan N, Stuver RN, Horwitz SM, Wudhikarn K, Hwang SR, Bennani NN, Chavez JC, Sokol L, Saeed H, Duan F, Porcu P, Pullarkat P, Mehta-Shah N, Zain J, Ruiz M, Brammer JE, Prakash R, Padmanabhan Iyer S, Olszewski AJ, Major A, Riedell PA, Smith SM, Goldin C, Haverkos BM, Hu B, Zhuang TZ, Allen PB, Toama W, Janakiram M, Jagadeesh D, Brooks TR, Hariharan N, Goodman AM, Hartmann G, Ghione P, Fayyaz F, Rhodes JM, Chong EA, Gerson JN, Landsburg DJ, Nasta SD, Schuster SJ, Svoboda J, Jerkeman M, Barta SK. Bhansali RS, et al. Among authors: rhodes jm. Blood Adv. 2024 May 13:bloodadvances.2024012800. doi: 10.1182/bloodadvances.2024012800. Online ahead of print. Blood Adv. 2024. PMID: 38739715

10

Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis.

Kittai AS, Hang Y, Bhat SA, Clark A, Grever M, Rhodes JM, Roberts M, Rogers KA, Teschemaker A, Munoz-Sagastibelza M, Woyach JA, Barrientos JC. Kittai AS, et al. Among authors: rhodes jm. Am J Hematol. 2024 Apr;99(4):780-784. doi: 10.1002/ajh.27241. Epub 2024 Feb 15. Am J Hematol. 2024. PMID: 38357757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

386 results

Search Page